The largest database of trusted experimental protocols

Superase rnase inhibitor

Manufactured by Thermo Fisher Scientific
Sourced in United States

SUPERase RNase inhibitor is a laboratory reagent designed to protect RNA samples from degradation by RNase enzymes. It functions by inhibiting the activity of RNase enzymes, thereby preserving the integrity of RNA molecules during various experimental procedures.

Automatically generated - may contain errors

31 protocols using superase rnase inhibitor

1

Ribosome Profiling of Caenorhabditis elegans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrated lysis buffer was added to each frozen sample to a final concentration of 20 mM Tris-HCl (pH = 7.4), 150 mM NaCl, 5mM MgCl2, 0.5X Protease Inhibitor (Sigma, Cat:P2714), 1 mM DTT, 0.1 mg/mL cycloheximide (Millipore, Cat:C4859), 1% (v/v) Triton X-100 and 5 U/mL Turbo DNase (Invitrogen, Cat:AM2238) (Ingolia et al., 2012 (link)), and worm pellets were kept on ice until fully thawed. Suspended worms were transferred to 400 μm silica beads tube (OPS Diagnostic, Cat: PFAW-400-100-04) and lysed in bead beater homogenizer for 4 min at 4°C. Lysates were then centrifuged at 25,000 rcf for 10 min at 4°C, and supernatants were collected. To generate monosomes, RNase I (Invitrogen, Cat: AM2294) was added to a final concentration of 0.2 U per μl of harvested worm pellet. The digestion was incubated at room temperature for 40 min with gentle rotation and then quenched by adding SUPERase RNase Inhibitor (Invitrogen, Cat: AM2694) at 4 U per RNase I unit. The lysates were then loaded onto 5-40% (m/v) sucrose gradients prepared with lysis buffer without Triton X-100 and centrifuged at 32,000 rpm for 3 h at 4°C in an SW41Ti rotor (Beckman Coulter, Cat:331362). The sucrose gradients were fractionated using BR-188 Density Gradient Fractionation System with 60% (m/v) sucrose as chase solution, and monosome fractions were collected according to OD254 profiles.
+ Open protocol
+ Expand
2

HIV-1 pol Gene cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first step in the assay is reverse transcription of the RNA template into cDNA. cDNA synthesis was completed with final concentrations of 1X AffinityScript RT buffer (600107, Agilent Technologies, Santa Clara, CA), 5 mM DTT (600107, Agilent Technologies, Santa Clara, CA), 1 U/μL SUPERase RNase Inhibitor (AM2694, Invitrogen, Carlsbad, CA), 0.05 U/μL HIV Reverse Transcriptase (HIV RT P66/51, AbCam), 1.5 μM dNTP mix (R0192, Fisher Scientific, Houston, TX), and 0.42 μM HIV reverse primer (Integrated DNA Technologies, Coralville, IA, USA) that contains the complementary sequence of a target region within the HIV-1 pol gene.53 (link) All reagents were diluted in nuclease free water (P1193, Promega, Madison WI). 7.8 × 103 copies of RNA template and TFV-DP ranging from 0 to 1250 nM (166403-66-3, BOC Sciences Inc.) were spiked into each reaction mix. The final reaction volume was 20 μL. The cDNA synthesis was performed at 39 °C in a heating block (T16, Axxin, Australia) for 10 minutes. After cDNA synthesis, RT enzyme was deactivated at 70 °C for 5 minutes in a mini dry block heater (VWR, Radnor, PA) to remove reverse transcription activity.
+ Open protocol
+ Expand
3

Cell-free Expression of Csx30-3 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
3xHA tagged forms of Csx30–3 were cloned into pCDNA3.1 vectors and amplified by PCR using oligos containing the T7 promoter and terminator. Cell-free transcription-translation was performed using PURExpress (New England Biolabs) in 5 μL reactions containing 2 μL buffer A, 1.5 μL buffer B, 0.25 μL of Superase RNAse Inhibitor (Invitrogen), and 50–100 ng of PCR template. Reactions were incubated for 2 h at 37°C and directly transferred to in vitro reactions.
+ Open protocol
+ Expand
4

Efficient mRNA Delivery into NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before transfection, devices were passivated with NK MACS medium. NK cells were washed with DPBS, and prepared in NK MACS medium with 1:1000 Superase RNase inhibitor (Invitrogen), at a concentration of 2 million cells/ml. CleanCap eGFP mRNA (TriLink) was added to the cells with a concentration ranging from 20 to 80 µg/ml. Unless stated otherwise, the mix of NK cells and payload was flowed through a microfluidic device of 3.5 µm gap size device at a flow rate of 800 µl/min, and an mRNA concentration of 60 µg/ml. 250 µl of sample were processed per channel, and plated in a 24-well plate already containing 250 µl of 2× complete NK medium. Cell counts were performed after VECT transfection with NucleoCounter NC-3000 (ChemoMetec), using A8 slides (ChemoMetec) and solution 13 (ChemoMetec) as per manufacturer instructions. Cells were placed in the incubator for cell culture.
+ Open protocol
+ Expand
5

Efficient HSPC Transfection via VECT

Check if the same lab product or an alternative is used in the 5 most similar protocols
VECT medium (X-VIVO 10 Media (Lonza), and 1:1000 Superase RNase inhibitor (Invitrogen)) and complete HSPC medium (see Thawing of CD34+ HSPCs) were prepared. VECT microfluidic devices were passivated with 0.5 ml VECT medium per channel. HSPCs were spun at 300g for 5 min, washed with nuclease-free DPBS, and placed in HSPC VECT medium at 2 million cells/ml. Before VECT, CleanCap eGFP mRNA (TriLink) was added to the cells to achieve a final concentration of 160 µg/ml. For each sample, 200 µl HSPCs were flown through a 4 µm gap size device at a rate of 800 µl/min, into another 200 µl of pre-incubated 2× complete HSPC medium. Cell counts were performed after VECT transfection with NucleoCounter NC-3000 (ChemoMetec), using A8 slides (ChemoMetec) and solution 13 (ChemoMetec) as per manufacturer instructions. Lastly, samples were incubated at 37 °C, 5% CO2for 24 h before analysis.
+ Open protocol
+ Expand
6

Microfluidic Delivery of mRNA to T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activated T cells were flown through a microfluidic device at a flow rate of 400 µl/min. Microfluidic devices were first passivated with TexMACS (Miltenyi Biotec). T cells were spun down at 300G for 5 min and washed with PBS. Cells were resuspended between 2 and 3 million cells/ml in T cell VECT Buffer: TexMACS (Miltenyi Biotec), and 1:1,000 Superase RNase inhibitor (Invitrogen). Before VECT transfection, CleanCap eGFP mRNA (TriLink) payload was added to the cells. 250 µl of reaction were processed per channel and plated in a 24-well plate already containing 250 µl complete T cell medium. Unless stated otherwise, the mix of T cells and payload was flowed through a microfluidic device of 4 µm gap size device at a flow rate of 800 µl/min, and an mRNA concentration of 70 µg/ml. Cell counts were performed after VECT transfection with NucleoCounter NC-3000 (ChemoMetec), using A8 slides (ChemoMetec) and solution 13 (ChemoMetec) as per manufacturer instructions.
+ Open protocol
+ Expand
7

Enteroid RNA Isolation and Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was isolated from two pooled enteroid monolayers using TRIzol (Invitrogen) and the Direct-zol miniprep (Zymo Research) according to manufacturer’s protocol. Genomic DNA was removed with the TURBO DNA free kit (Invitrogen) in presence of SUPERase RNAse inhibitor (Invitrogen). cDNA was made with the Superscript IV first strand synthesis kit (Invitrogen) using oligo(dT)20 and random hexamers. Gene expression was assessed by PCR using the cDNA as template, the primers listed in the supplemental material (Table S5) and the GO Taq PCR kit (Promega). Amplicons were visualized on a 1% agarose gel.
+ Open protocol
+ Expand
8

RNA-Protein Binding Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA-protein binding assays were carried out by following the method described by Satoh et al. (8 (link)) with slight modifications. Exponentially growing cells (4 × 108 total cells) expressing N-terminally glutathione S‐transferase (GST)-tagged wild-type or mutated Rnc1 proteins were disrupted in 500 μl extraction buffer (30 mM Tris HCl, pH 8, 1% Triton X-100, 2 mM EDTA, 1 mM dithiothreitol [DTT], plus protease and phosphatase inhibitor cocktails [obtained from Sigma-Aldrich and Roche Molecular Biochemicals, respectively]). Glutathione-Sepharose 4B (GE Healthcare, USA) was added to the cleared extracts, which were incubated for 2 h at 4°C. Sepharose was washed seven times in wash buffer (30 mM Tris HCl, pH 8, 1% Triton X-100, 2 mM EDTA, 1 mM DTT, 3 M NaCl plus phosphatase inhibitor cocktail) and two times in binding buffer (30 mM Tris HCl, pH 8, 1% Triton X-100, and 1 mM DTT). Fission yeast total RNA (100 μg) and 100 U ml−1 SUPERase RNase inhibitor (Invitrogen) were added to the washed Sepharose containing equivalent amounts of the purified GST-Rnc1 fusion and incubated for 2 h at 4°C. After two washes in binding buffer, the RNA bound to Sepharose was extracted with the RNeasy minikit (Qiagen, Germany). cDNA synthesis (10 μl RNA) and qPCR were performed as described above.
+ Open protocol
+ Expand
9

Total RNA Extraction and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from 50 mg of bulk tissue using Trizol reagent according to manufacturer’s instructions (Ambion). To remove any residual DNA, RNA samples were treated with DNAse I (Ambion) using 2 U every 10 μg of RNA added with SUPERaseRNAse inhibitor (Invitrogen) in a reaction volume of 50 μL and incubated at 37°C for 30 min. After treatment, enzyme was inactivated and RNA was purified using Cleanup RNeasy® Mini kit according to manufacturer’s instructions (QIAGEN). The RNA concentration and purity were determined by spectrophotometric measurement using NanoDrop 2000 (Thermo Fisher Scientific) and by running denaturing formaldehyde agarose gel.
+ Open protocol
+ Expand
10

RNA Isolation and qPCR Analysis of Neurotransmitter Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
To isolate RNA, T cells (either FACS sorted or MACS purified, as required) were spun down, the pellets loosened and resuspended in TRIZOL (Invitrogen). These cell lysates were further homogenized by applying to QIAshredder columns (Qiagen). The filtrate from the column was combined with 100 μL of chloroform and incubated at room temperature for 2 min. After centrifugation (17,000g for 15 min), the aqueous layer was collected and combined with an equal volume of 70% ethanol. The RNA mixture was then purified using the Qiagen RNeasy Mini kit. Briefly, the RNA mixture was applied to a Qiagen RNeasy, washed once each with 700 μL of RPE buffer and 500 μL 80% ethanol, and eluted with 50 μL PCR-grade water with 20 U of SUPERase RNase inhibitor added (Invitrogen). RNA yield and quality were determined using a NanoVue Plus (GE). For RT-qPCR, ~250 ng of RNA per sample was converted to cDNA using the Qiagen RT2 First Strand kit, including the genomic DNA elimination step, and then applied to the Qiagen RT2 Profiler PCR Array Mouse Neurotransmitter Receptors. qPCR was performed using ABI 7900HT.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!